Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SirCat: Atorvastatin for Hypertrophic Cardiomyopathy
NCT00317967Phase 3Completed
- Sponsor
- University of Calgary
- Start
- Apr 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in hypertrophic cardiomyopathy (HCM), sponsored by University of Calgary. Started Apr 2007; status: completed.
02
Drugs
atorvastatin
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT00317967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317967.